Browser storage is unavailable. Keep this page open and export your collection before leaving.
CONUS structures fragmented medical device information for surgeons. We combine manufacturer documentation, hospital protocols and medical research in one place, giving surgeons and MedTech teams reliable answers across products and procedures. We already work with leading manufacturers including Johnson & Johnson, Stryker and Zimmer Biomet, and
CONUS structures fragmented medical device information for surgeons. We combine manufacturer documentation, hospital protocols and medical research in one place, giving surgeons and MedTech teams reliable answers across products and procedures.
We already work with leading manufacturers including Johnson & Johnson, Stryker and Zimmer Biomet, and since launching six months ago we’ve gone live in 22 hospitals.
Long term, hospitals will use CONUS to select and order implants across manufacturers.
Former PhD researcher on generative and agentic AI with ETH Zurich. Part of the core team driving GenAI adoption across Bosch, from strategy to company-wide rollout. Previously in healthcare strategy consulting.
Industrial engineer and former AI researcher at ETH Zurich. Joined Cleansort as engineer #10 and helped scale it from prototype-stage startup to 50+ employees, building across hardware, manufacturing and automation software.
Electrical engineer from RWTH Aachen, Germany. Built high-speed electronics and embedded software for biomedical instruments at Miltenyi Biotec, one of Europe’s largest biotech companies scaled to 5,000+ employees.
CONUS started with five chief orthopedic and trauma surgeons who wanted better access to the information their teams need every day. The three of us had already worked together for years, combining backgrounds in AI, biomedical engineering and product development.
Source-based assessment · automated evidence rules
The retained text does not establish product availability or customer use.
Maturity is an evidence-based assessment, not a success rating. It may understate the current stage where evidence is limited. Coverage records documented areas, not a complete or independently audited company history.